Clinical Trial Update: Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Adults With Facial isSCC [Phase 1, Phase 2]

View source ↗

Summary

A study evaluating the safety and efficacy of intralesional STP705 for facial intraepithelial squamous cell carcinoma has completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facial Intraepithelial Squamous Cell Carcinoma

Drugs mentioned

• STP705

Snippet

Sponsor: Sirnaomics | Conditions: Facial isSCC | Phase 1, Phase 2 | Status: COMPLETED